Evidence map›Paper›PMID 42708366›Full record

ArticleJCI insight2026

A familial case of FLAD1 protein deficiency associated with impaired adrenal steroidogenesis.

Olga A Averina, Natalia Yu Kalinchenko, Vitaly A Ioutsi, Andrey V Pirogov, Alexander V Bogachev, Oleg A Permyakov, Vitaly S Buev, Ekaterina A Guseva, Anastasia V Priymak, Olga A Bazhanova and 8 more

Abstract readCase Reports
In one paragraph

Article in JCI insight, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Olga A AverinaBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia.
Natalia Yu KalinchenkoEndocrinology Research Centre, Moscow, Russia.
Vitaly A IoutsiEndocrinology Research Centre, Moscow, Russia.
Andrey V PirogovFaculty of Chemistry, Lomonosov Moscow State University, Moscow, Russia.
Alexander V BogachevBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia.
Oleg A PermyakovBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia.
Vitaly S BuevBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia.
Ekaterina A GusevaBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia.
Anastasia V PriymakBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia.
Olga A BazhanovaResearch Centre for Medical Genetics, Moscow, Russia.
Mariia A EmelianovaCenter for Bio- and Medical Technologies, Skolkovo Institute of Science and Technology, Skolkovo, Russia.
Olga O GrigoryevaBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia.
Galina V BaydakovaResearch Centre for Medical Genetics, Moscow, Russia.
Maxim A AbakumovPirogov Russian National Research Medical University, Moscow, Russia.
Vasily N ManskikhBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia.
Olga A DontsovaBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia.
Petr V SergievBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia.
Anatoly N TiulpakovResearch Centre for Medical Genetics, Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The FLAD1 gene codes for flavin adenine dinucleotide (FAD) synthase. FAD is a cofactor for many redox enzymes involved in vital processes from respiration to signal transduction. In this work, we described a clinical case of 2 siblings carrying compound heterozygous mutations in the FLAD1 gene resulting in the substitutions A418V and R542* at the protein level. The patients demonstrate adrenal insufficiency, which has not previously been associated with FLAD1 protein defects. To verify that adrenal insufficiency is caused by FLAD1 mutations, we created a personalized mouse model carrying the mutations found in the patients. The mutation in the FLAD1 gene, leading to the A418V substitution, appeared viable in the homozygous state, with minimal difference from the WT. The FLAD1 gene mutation leading to the R542* truncation is lethal when homozygous. The mouse model of the compound heterozygous FLAD1A418V/R542* mutations recapitulated the physiological, biochemical, and endocrine manifestations of FLAD1 mutations in patients. The mouse model created demonstrates the causal effect of FLAD1 mutations on the described pathology and potentially paves the way for understanding the disease's molecular mechanism and developing better therapies.

Indexed as

Adrenal InsufficiencyAnimalsDisease Models, AnimalFemaleHomozygoteHumansMaleMiceMutationBioenergeticsEndocrinologyGenetic diseasesGeneticsMetabolismMouse models

Identifiers

PMID42708366
PMCPMC13564092

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.